)
)
)
KAHR Medical
KAHR Medical develops novel bi-functional, immunotherapeutic fusion proteins for the treatment of cancer. Our lead compound, DSP107 is in a phase 2b trial in fourth line metastatic colorectal cancer.
Address
Modi'in Makabim-Re'utIsrael
Israel
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)